The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 10, 2017

Filed:

May. 22, 2015
Applicant:

Ltt Bio-pharma Co., Ltd., Minato-ku, Tokyo, JP;

Inventors:

Toru Mizushima, Tokyo, JP;

Hongxing Liu, Tokyo, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/452 (2006.01); C07D 211/46 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01);
U.S. Cl.
CPC ...
A61K 31/452 (2013.01); A61K 9/007 (2013.01); A61K 9/0031 (2013.01); A61K 9/0053 (2013.01); A61K 9/0078 (2013.01); A61K 9/2018 (2013.01);
Abstract

This invention provides a safe and effective agent for ameliorating chronic obstructive pulmonary disease (COPD) that has both a bronchodilator effect and an anti-inflammatory effect. The agent for ameliorating chronic obstructive pulmonary disease contains mepenzolate bromide as an active ingredient. More preferably the mode of administration of the agent for ameliorating chronic obstructive pulmonary disease is airway administration or inhalation administration, and furthermore the mode of administration thereof is oral administration or rectal administration. This invention is a safe and effective agent for ameliorating chronic obstructive pulmonary disease (COPD) that has both a bronchodilator effect and an anti-inflammatory effect of mepenzolate bromide.


Find Patent Forward Citations

Loading…